Valuation Eckert & Ziegler SE London S.E.
Stocks
0NZY
DE0005659700
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
Pre-market 02:18:34 | |||
| 13.42 EUR | +0.15% |
|
13.66 | +1.75% |
| 07-22 | Eckert & Ziegler: BaFin reviews 2024 financial statements over Pentixapharm spin-off | DP |
| 07-22 | Eckert & Ziegler next in BaFin's sights, shares rebound | DP |
Company Valuation: Eckert & Ziegler SE
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,953 | 963.5 | 859.6 | 927.6 | 954.9 | 856.7 | - | - |
| Change | - | -50.67% | -10.79% | 7.92% | 2.94% | -10.28% | - | - |
| Enterprise Value (EV) 1 | 1,885 | 903.2 | 818.9 | 847.9 | 839.6 | 740.6 | 731.2 | 702.7 |
| Change | - | -52.09% | -9.34% | 3.55% | -0.97% | -11.8% | -1.27% | -3.9% |
| P/E | 56.7x | 32.9x | 32.8x | 28x | 19.6x | 16.5x | 15.5x | 13.9x |
| PBR | - | - | - | - | 3.79x | 2.85x | 2.55x | 2.28x |
| PEG | - | -2.2x | -3.1x | 1.1x | 0.4x | 2.49x | 2.53x | 1.2x |
| Capitalization / Revenue | 10.8x | 4.34x | 3.49x | 3.14x | 3.06x | 2.69x | 2.52x | 2.31x |
| EV / Revenue | 10.4x | 4.06x | 3.33x | 2.87x | 2.69x | 2.32x | 2.15x | 1.9x |
| EV / EBITDA | 33x | 16.3x | 13.9x | 10.8x | 9.25x | 7.79x | 7.23x | 6.33x |
| EV / EBIT | 39.7x | 20.3x | 18x | 14.1x | 11.4x | 9.47x | 8.86x | 7.65x |
| EV / FCF | 377x | 285x | 38.8x | 17.2x | 25.9x | 18.8x | 19.7x | 12x |
| FCF Yield | 0.27% | 0.35% | 2.58% | 5.82% | 3.86% | 5.31% | 5.08% | 8.3% |
| Dividend per Share 2 | 0.1667 | 0.1667 | 0.0167 | 0.1667 | - | 0.195 | 0.2 | 0.3753 |
| Rate of return | 0.53% | 1.08% | 0.12% | 1.12% | - | 1.42% | 1.46% | 2.74% |
| EPS 2 | 0.5533 | 0.47 | 0.42 | 0.53 | 0.78 | 0.8316 | 0.8825 | 0.9847 |
| Distribution rate | 30.1% | 35.5% | 3.97% | 31.4% | - | 23.4% | 22.7% | 38.1% |
| Net sales 1 | 180.4 | 222.3 | 246.1 | 295.8 | 312 | 318.7 | 340.5 | 370.7 |
| EBITDA 1 | 57.04 | 55.52 | 58.83 | 78.8 | 90.82 | 95.05 | 101.1 | 111 |
| EBIT 1 | 47.45 | 44.54 | 45.45 | 59.95 | 73.74 | 78.22 | 82.56 | 91.91 |
| Net income 1 | 34.53 | 29.28 | 26.3 | 33.28 | 48.76 | 51.68 | 53.08 | 59.41 |
| Net Debt 1 | -68.05 | -60.3 | -40.68 | -79.72 | -115.2 | -116.1 | -125.5 | -154 |
| Reference price 2 | 31.37 | 15.47 | 13.77 | 14.83 | 15.26 | 13.69 | 13.69 | 13.69 |
| Nbr of stocks (in thousands) | 62,269 | 62,296 | 62,437 | 62,536 | 62,574 | 62,577 | - | - |
| Announcement Date | 3/30/22 | 3/30/23 | 3/22/24 | 3/26/25 | 3/25/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 60.34x | 4.65x | 15.58x | 0.35% | 15.69B | |
| 40.66x | - | - | 1.99% | 1.74B | |
| -10.42x | 1.29x | 5.68x | -.--% | 1.14B | |
| 50.65x | - | - | 0.88% | 517M | |
| 47.87x | - | - | - | 470M | |
| 18.37x | 2.59x | 11.06x | 1.85% | 376M | |
| 24.39x | 4.19x | 14.12x | 1.9% | 355M | |
| 116.05x | 17.36x | 107.93x | - | 289M | |
| Average | 43.49x | 6.02x | 30.87x | 1.16% | 2.57B | |
| Weighted average by Cap. | 53.63x | 4.59x | 16.32x | 0.55% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- EUZ Stock
- 0NZY Stock
- Valuation Eckert & Ziegler SE
Select your edition
All financial news and data tailored to specific country editions
